Advertisement
Research Article| Volume 81, ISSUE 1, P116-121, January 1973

Studies on hypermuramidasemia in the normal and chloroleukemic rat: The role of the kidney

  • Joel S. Greenberger
    Affiliations
    From the Peter Bent Brigham Hospital Boston, Mass. U.S.A.

    From the Harvard Medical School, Boston, Mass. U.S.A.
    Search for articles by this author
  • David S. Rosenthal
    Correspondence
    Reprint requests: Drs. David S. Rosenthal or William C. Moloney, 721 Huntington Ave., Boston, Mass. 02115.
    Affiliations
    From the Peter Bent Brigham Hospital Boston, Mass. U.S.A.

    From the Harvard Medical School, Boston, Mass. U.S.A.
    Search for articles by this author
  • William C. Moloney
    Correspondence
    Reprint requests: Drs. David S. Rosenthal or William C. Moloney, 721 Huntington Ave., Boston, Mass. 02115.
    Affiliations
    From the Peter Bent Brigham Hospital Boston, Mass. U.S.A.

    From the Harvard Medical School, Boston, Mass. U.S.A.
    Search for articles by this author
      This paper is only available as a PDF. To read, Please Download here.

      Abstract

      Clearance of muramidase (lysozyme) was studied in the normal and chloroma-bearing rat. The chloroma-bearing rat often develops a leukemic blood picture resembling human acute myelogenous leukemia and demonstrates markedly elevated serum and urinary muramidase activity. Both solid tumor bearing, nonleukemic (chloromatous) rats and acutely leukemic (chloroleukemic) rats were studied. Intravenously injected, purified rat muramidase was rapidly cleared from normal and leukemic rats. However, nonleukemic chloroma-bearing animals, known to have chronically elevated serum muramidase levels showed delayed enzyme clearance. These observations support the theory that chronic, but not acute, elevation of enzyme activity can overload the mechanism for renal muramidase degradation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Translational Research
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Finch SC
        • Gnabasic EJ
        • Rogoway W
        Lysozyme and leukopoiesis.
        in: Proceedings Third International Symposium on Fleming's Lysozyme, Milan Secuola Arti Grafiche, O.S.F, Cesano Boscone1964
        • Osserman EF
        • Lawlor DP
        Serum and urinary lysozyme in monocytic and monomyelocytic leukemia.
        J Exp Med. 1966; 124: 921-952
        • Rosenthal DS
        • Moloney WC
        Muramidase activity in leukemic rats.
        in: Proc Soc Exp Biol Med. 126. 1967: 682-685
        • Shay H
        • Gruenstern M
        • Mary HE
        • et al.
        The development of lymphatic and myelogenous leukemia in Wistar-Furth rats following gastric installations of methylchloranthrene.
        Cancer Res. 1951; 11: 29-34
        • Alderton G
        • Ward WH
        • Ferold HL
        Isolation of lysozyme from egg white.
        J Biol Chem. 1945; 157: 43-57
        • Keeler R
        The effect of bilateral nephrectomy on the production and distribution of muramidase (lysozyme) in the rat.
        Can J Physiol Pharmacol. 1970; 48: 131-137
        • Hansen NE
        • Karle H
        • Andersen V
        Lysozyme turnover in the rat.
        J Clin Invest. 1971; 50: 1473-1477
        • Osserman EF
        • Azar HA
        Renal tubular lesions secondary to lysozyme in human and rat monocytic leukemia.
        in: Fed Proc. 28. 1969: 619
        • Maack T
        Changes in activity of acid hydrolases during reabsorption of lysozyme.
        J Cell Biol. 1967; 35: 268-273
        • Glynn AA
        Lysozyme, Antigen, Enzyme and Anti-Bacterial Agent.
        Annual Rev. 1968; 31
        • Muggia FM
        • Heinemann HO
        • Farhani M
        • et al.
        Lysozymuria and renal tubular dysfunction in monocytic and monomyelocytic leukemia.
        Am J Med. 1969; 47: 35-65
      1. Rosenthal DS, Maglio R, and Moloney WC: Muramidasuria and hyperkaluria in the chloroleukemic rat. Proc Soc Exp Biol Med (In press.)

        • Skarin AT
        • Matsuo Y
        • Moloney WC
        Muramidase in myeloproliferative disorders terminating in acute leukemia.
        Cancer. 1972; 29: 1336-1342